JO
ICVX

John Overdeck’s Icosavax, Inc. Common Stock ICVX Stock Holding History

John Overdeck’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-20,034
Closed -$199K – 3330
2023
Q2 		$199K Sell
20,034
-75,339
-79% -$603K ﹤0.01% 2644
2023
Q1 		$553K Buy
95,373
+19,910
+26% +$172K ﹤0.01% 2160
2022
Q4 		$599K Buy
75,463
+16,832
+29% +$72.2K ﹤0.01% 1947
2022
Q3 		$185K Buy
+58,631
New +$367K ﹤0.01% 2128

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $443M AUM 49.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

John Overdeck's ICVX Position: Q3 2023 in Review

John Overdeck sold out of Icosavax, Inc. Common Stock (ICVX) in Q3 2023, closing a stake of 20,034 shares — an estimated $199K sold.

John Overdeck first reported a position in ICVX in Q3 2022 and held it in 4 quarters. The position peaked at $599K in Q4 2022. 64 funds tracked by Wall St. Rank hold ICVX as of Q3 2023.

  • John Overdeck reported no remaining Icosavax, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • John Overdeck sold 20,034 Icosavax, Inc. Common Stock shares in Q3 2023, an estimated $199K.
  • John Overdeck first reported a position in Icosavax, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
  • John Overdeck's Icosavax, Inc. Common Stock position peaked at $599K in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.